MedPath

To test the moisturization of products.

Phase 4
Completed
Registration Number
CTRI/2024/01/061163
Lead Sponsor
Salicylates & Chemicals Pvt. Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Gender: Male or Female with age 18-40

2) Subjects willing to give written informed consent

3) Women of child bearing potential must have a negative urine

pregnancy test prior to study entry.

4) Are free of any systemic or dermatologic disorder, which, in

the opinion of the investigator, will interfere with the study

results or increase the risk of adverse events.

5) Are willing to avoid prolonged exposure of the treatment area

to ultraviolet radiation (natural or artificial) for the duration of

the study.

Exclusion Criteria

1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.

2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.

3. Have open sores or open lesions in the treatment area(s).

4. Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the

product.

5. Have participated in any interventional clinical trial in the previous 90 days.

6. Have a known sensitivity to any of the constituents of the test product.

7. Have used, are using, or are planning to use

immunosuppressive or immunomodulatory medication (i.e.,biologics), including corticosteroids.

8. Have not skin related issues

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in MoistureTimepoint: T0min, T+30 mins, T+ 2 hours, T+4 hours, T+ 6 hours, T+8 hours
Secondary Outcome Measures
NameTimeMethod
ot applicableTimepoint: Not applicable
© Copyright 2025. All Rights Reserved by MedPath